12 Prevalence of transthyretin amyloid cardiomyopathy (aTTR-CM) in undifferentiated HFpEF
12 Prevalence of transthyretin amyloid cardiomyopathy (aTTR-CM) in undifferentiated HFpEF
About this item
Full title
Author / Creator
Healy, L , Giblin, G , O’Sullivan, D , Kavanagh, E , Howley, E , Tracey, C , O’Neill, J , Joyce, E , O’Connell, M , McDaid, A , Clarke, A , Gray, A and Mahon, N
Publisher
London: BMJ Publishing Group Ltd and British Cardiovascular Society
Journal title
Language
English
Formats
Publication information
Publisher
London: BMJ Publishing Group Ltd and British Cardiovascular Society
Subjects
More information
Scope and Contents
Contents
IntroductionTransthyretin amyloid cardiomyopathy (aTTR-CM) is an increasingly recognised cause of heart failure with preserved ejection fraction (HFpEF) which may be diagnosed non-invasively with SPECT/CT 99m-3,3-diphosphono-1,2-propanodicarboxylic acid (DPD) scintigraphy. The diagnosis of aTTR-CM has assumed greater relevance with the growing avai...
Alternative Titles
Full title
12 Prevalence of transthyretin amyloid cardiomyopathy (aTTR-CM) in undifferentiated HFpEF
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_2724284034
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2724284034
Other Identifiers
ISSN
1355-6037
E-ISSN
1468-201X
DOI
10.1136/heartjnl-2022-ICS.12
